Stockscreener 앱 받기
95.59
1.95%
-1.90
시장 영업 전:
97.01
1.42
+1.49%
전일 마감가:
$97.49
열려 있는:
$98.55
하루 거래량:
349.10K
Relative Volume:
1.16
시가총액:
$2.18B
수익:
$256.28M
순이익/손실:
$62.40M
주가수익비율:
35.22
EPS:
2.7139
순현금흐름:
$79.12M
1주 성능:
-5.94%
1개월 성능:
+3.62%
6개월 성능:
+13.50%
1년 성능:
+18.35%
1일 변동 폭
$95.28
$100.59
1주일 범위
$95.28
$102.53
52주 변동 폭
$79.00
$118.01
Lemaitre Vascular Inc Stock (LMAT) Company Profile
명칭
Lemaitre Vascular Inc
전화
781-221-2266
주소
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
95.59 | 2.18B | 256.28M | 62.40M | 79.12M | 2.7139 |
ISRG
Intuitive Surgical Inc
|
337.50 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
156.36 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.91 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
38.75 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
195.27 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-02-13 | 개시 | Wells Fargo | Equal Weight |
| 2024-10-15 | 개시 | Cantor Fitzgerald | Neutral |
| 2024-08-02 | 재개 | Lake Street | Buy |
| 2024-05-31 | 재개 | ROTH MKM | Buy |
| 2024-04-26 | 업그레이드 | Stifel | Hold → Buy |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-06 | 개시 | Oppenheimer | Outperform |
| 2023-08-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-05-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | 개시 | Jefferies | Buy |
| 2021-02-12 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | 업그레이드 | Sidoti | Neutral → Buy |
| 2019-10-24 | 다운그레이드 | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | 업그레이드 | Lake Street | Hold → Buy |
| 2019-10-14 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | 재확인 | Barrington Research | Outperform |
| 2019-07-25 | 업그레이드 | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2018-06-08 | 재개 | ROTH Capital | Buy |
| 2018-04-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-04-26 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2017-10-27 | 다운그레이드 | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2017-07-10 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2017-03-21 | 개시 | First Analysis Sec | Overweight |
| 2017-02-22 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2016-07-28 | 재확인 | Barrington Research | Outperform |
| 2016-02-25 | 재확인 | Barrington Research | Outperform |
모두보기
Lemaitre Vascular Inc 주식(LMAT)의 최신 뉴스
LeMaitre Vascular, Inc. Revenue Breakdown – NASDAQ:LMAT - TradingView
TradingKey - TradingKey
LeMaitre Vascular Inc (LMAT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LMAT|LeMaitre Vascular Inc|Price:95.638|Chg%:-1.852 - TradingKey
LMAT|LeMaitre Vascular Inc|Price:98.390|Chg%:+0.900 - TradingKey
LMAT|LeMaitre Vascular Inc|Price:97.100|Chg%:-0.390 - TradingKey
First Trust Advisors LP Acquires 57,931 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular Inc (LMAT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Citizens reiterates LeMaitre Vascular stock rating on growth outlook By Investing.com - Investing.com Canada
LeMaitre Vascular (LMAT) Slips 1.36% as Stock Tests Key Support LevelsVolume Gap - dars.gov.et
Technical Reactions to LMAT Trends in Macro Strategies - Stock Traders Daily
Bessemer Group Inc. Boosts Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Copeland Capital Management LLC Has $95.05 Million Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LMAT6268257 Bond Risk Profile - TradingView
LMAT6268257 Bond Coupon Profile — Rate & Payments - TradingView
LMAT6268257 Bond Profile — Key Metrics - TradingView
LeMaitre Vascular (NASDAQ:LMAT) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
LeMaitre Vascular to Report Second Quarter 2026 Financial Results on August 4 - Quiver Quantitative
LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026 - The Manila Times
LeMaitre Schedules Aug. 4 Call to Discuss Second-Quarter Results - Stock Titan
LeMaitre Vascular (NASDAQ:LMAT) Cut to "Hold" at Zacks Research - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
LeMaitre Vascular, Inc. $LMAT Shares Sold by Dividend Assets Capital LLC - MarketBeat
LeMaitre Vascular Inc. (LMAT) Q1 2026 Earnings: EPS Beats Estimates, Shares Climb 4%ROIC Trend Report - dars.gov.et
LeMaitre Vascular (NASDAQ:LMAT) Upgraded to "Buy" at Wall Street Zen - MarketBeat
LMAT Q1 2026 Earnings: Small EPS Beat Amid Steady PerformanceRevenue Inflection Point - dars.gov.et
LeMaitre Vascular (LMAT) Gains 4.2%: Key Technical Levels and Potential ScenariosWave Alternation - dars.gov.et
LeMaitre Vascular, Inc. $LMAT is Conestoga Capital Advisors LLC's 7th Largest Position - MarketBeat
LeMaitre Vascular, Inc. Financial Disclosures & Filings - TradingView
LMATLemaitre Vascular Inc Latest SEC Filings - Finviz
LeMaitre Vascular, Inc. $LMAT Shares Sold by SG Americas Securities LLC - MarketBeat
LMAT Technical Analysis & Stock Price Forecast - Intellectia AI
Trading the Move, Not the Narrative: (LMAT) Edition - Stock Traders Daily
Enterprise value to EBITDA forward of LeMaitre Vascular, Inc. – NASDAQ:LMAT - TradingView
Price to sales forward of LeMaitre Vascular, Inc. – NASDAQ:LMAT - TradingView
Price to book forward of LeMaitre Vascular, Inc. – NASDAQ:LMAT - TradingView
Enterprise value to EBIT forward of LeMaitre Vascular, Inc. – NASDAQ:LMAT - TradingView
LeMaitre Vascular, Inc. Actuals & Estimates (NASDAQ:LMAT) - TradingView
LeMaitre Vascular, Inc. Actuals & Estimates (SWB:LHU) - TradingView
LeMaitre Vascular Inc (LMAT) Institutional Confidence - TradingKey
LMAT Forecast — Price Target — Prediction for 2027 - TradingView
LeMaitre Vascular, Inc. Actuals & Estimates (TRADEGATE:LHU) - TradingView
LHU Forecast — Price Target — Prediction for 2027 - TradingView
Rockefeller Capital Management L.P. Sells 100,923 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
Riverbridge Partners LLC Buys Shares of 105,599 LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular Inc. (NASDAQ:LMAT) Passes the Quality Test with Caviar Cruise Screen - ChartMill
LeMaitre Vascular Inc (LMAT) Valuation: PE, PB & Fair Value Analysis - TradingKey
LeMaitre Vascular Inc. (LMAT) Q1 2026 Earnings: EPS Beats Estimates, Stock Edges HigherEarnings Revision Upgrade - dars.gov.et
LeMaitre Vascular (NASDAQ:LMAT) Rating Lowered to Hold at Wall Street Zen - MarketBeat
LeMaitre Vascular Inc (LMAT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LeMaitre Vascular Inc (LMAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lemaitre Vascular Inc (LMAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.37%
0.73%
자본화:
|
볼륨(24시간):